Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis
- 2 November 2010
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 74 (3), 332-339
- https://doi.org/10.1111/j.1365-2265.2010.03917.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary SyndromeDrugs, 2009
- Androgens and polycystic ovary syndromeCurrent Opinion in Endocrinology, Diabetes and Obesity, 2009
- Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical TrialJournal of Clinical Endocrinology & Metabolism, 2009
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndromeActa Endocrinologica, 2008
- Polycystic Ovarian SyndromeJournal of the CardioMetabolic Syndrome, 2006
- The effects of rosiglitazone and metformin on menstrual cyclicityand hirsutism in polycystic ovary syndromeGynecological Endocrinology, 2005
- Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivityFertility and Sterility, 2004
- Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells from Women with Polycystic Ovary Syndrome by Activating Its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction SystemJournal of Clinical Endocrinology & Metabolism, 1998
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeThe New England Journal of Medicine, 1996
- Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.JCI Insight, 1995